ONCIMMUNE HOLDINGS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23 GBX | -2.13% |
|
-16.67% | -8.73% |
| Feb. 29 | EARNINGS: Leeds awaiting Hemmers sale, Macfarlane ups full-year payout | AN |
| Feb. 29 | Oncimmune Holdings plc Provides Earnings Guidance for the Year 2024 | CI |
Valuation
| Fiscal Period: August | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Capitalization 1 | 67.59 | 69.59 | 59.1 | 93.03 | 129.2 |
| Enterprise Value (EV) 1 | 63.02 | 56.64 | 53.75 | 97.07 | 130 |
| P/E ratio | -13.5 x | -9.9 x | -7.21 x | -11 x | -26.1 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | 314 x | 290 x | 346 x | 183 x | 34.7 x |
| EV / Revenue | 293 x | 236 x | 314 x | 191 x | 34.9 x |
| EV / EBITDA | -12.1 x | -8.96 x | -6.31 x | -9.94 x | -25.8 x |
| EV / FCF | -19.5 x | -14 x | -11.3 x | -15.1 x | -38.3 x |
| FCF Yield | -5.14% | -7.14% | -8.87% | -6.61% | -2.61% |
| Price to Book | 13.5 x | 5.13 x | 7.51 x | -479 x | 24.7 x |
| Nbr of stocks (in thousands) | 51,011 | 61,588 | 63,212 | 63,503 | 69,084 |
| Reference price 2 | 1.325 | 1.130 | 0.9350 | 1.465 | 1.870 |
| Announcement Date | 11/3/17 | 11/5/18 | 11/4/19 | 11/6/20 | 11/2/21 |
1GBP in Million2GBP
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: August | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Net sales 1 | 0.215 | 0.24 | 0.171 | 0.509 | 3.722 |
| EBITDA 1 | -5.21 | -6.322 | -8.519 | -9.769 | -5.03 |
| EBIT 1 | -5.273 | -6.374 | -8.589 | -9.847 | -5.217 |
| Operating Margin | -2,452.56% | -2,655.83% | -5,022.81% | -1,934.58% | -140.17% |
| Earnings before Tax (EBT) 1 | -5.316 | -6.342 | -8.548 | -9.783 | -5.696 |
| Net income 1 | -5.023 | -6.342 | -8.012 | -8.459 | -4.628 |
| Net margin | -2,336.28% | -2,642.5% | -4,685.38% | -1,661.89% | -124.34% |
| EPS 2 | -0.0984 | -0.1142 | -0.1297 | -0.1336 | -0.0717 |
| Free Cash Flow 1 | -3.237 | -4.042 | -4.767 | -6.414 | -3.395 |
| FCF margin | -1,505.73% | -1,684.04% | -2,787.72% | -1,260.04% | -91.21% |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 11/3/17 | 11/5/18 | 11/4/19 | 11/6/20 | 11/2/21 |
1GBP in Million2GBP
Estimates
Balance Sheet Analysis
| Fiscal Period: August | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | 4.04 | 0.84 |
| Net Cash position 1 | 4.57 | 13 | 5.36 | - | - |
| Leverage (Debt/EBITDA) | - | - | - | -0.4131 x | -0.1664 x |
| Free Cash Flow 1 | -3.24 | -4.04 | -4.77 | -6.41 | -3.39 |
| ROE (net income / shareholders' equity) | -68.2% | -68.3% | -74.8% | -221% | -184% |
| ROA (Net income/ Total Assets) | -37.4% | -38.3% | -45% | -62.3% | -18.9% |
| Assets 1 | 13.42 | 16.57 | 17.79 | 13.57 | 24.55 |
| Book Value Per Share 2 | 0.1000 | 0.2200 | 0.1200 | -0 | 0.0800 |
| Cash Flow per Share 2 | 0.1000 | 0.2100 | 0.0800 | 0.0700 | 0.1200 |
| Capex 1 | 0.01 | 0.03 | 0.18 | 0.24 | 0.45 |
| Capex / Sales | 3.26% | 12.92% | 107.02% | 46.37% | 11.98% |
| Announcement Date | 11/3/17 | 11/5/18 | 11/4/19 | 11/6/20 | 11/2/21 |
1GBP in Million2GBP
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -8.73% | 21.23M | |
| +5.31% | 70.44B | |
| +10.97% | 8.94B | |
| -16.83% | 4.75B | |
| +43.48% | 4.5B | |
| +3.20% | 3.85B | |
| +18.82% | 2.38B | |
| -21.36% | 2.34B | |
| -29.67% | 2.2B | |
| +8.38% | 1.96B |
- Stock Market
- Equities
- ONC Stock
- Financials Oncimmune Holdings plc
